This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Ludwig-Maximilians-Universitat München, Maastricht University, Academisch Ziekenhuis Maastricht. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 50 
2 out of 7 
1 out of 28 
Years Active: 2016-2017
Title: Esther Lutgens: Innovator in Inflammatory Disease Treatment
Introduction
Esther Lutgens is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of chronic inflammatory diseases. With a total of two patents to her name, her work focuses on innovative therapeutic approaches.
Latest Patents
Esther Lutgens' latest patents include compounds that act as selective inhibitors of the CD40-TRAF6 interaction. These inventions are crucial as they provide new avenues for treating chronic inflammatory diseases. The patents also encompass pharmaceutical compositions that utilize these compounds, highlighting their potential as effective medicaments.
Career Highlights
Throughout her career, Esther has worked at prestigious institutions such as Ludwig-Maximilians-Universität München and Maastricht University. Her research has been instrumental in advancing our understanding of inflammatory processes and developing targeted therapies.
Collaborations
Esther has collaborated with notable colleagues, including Christian Weber and Gerry Nicolaes. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Esther Lutgens stands out as a dedicated inventor whose work is paving the way for new treatments in the realm of chronic inflammatory diseases. Her contributions are vital to the ongoing advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile